Evaluation of Efficiency in the Activation and Accrual of Interventional Clinical Trials at Cancer Centers
Background: Clinical trials represent a significant percentage of the time and cost to bring a drug through the development process and to Food and Drug Administration approval. Despite how critical these trials are to the drug development process, many studies are underpowered due to low accrual....
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
The University of Arizona.
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10150/612064 http://arizona.openrepository.com/arizona/handle/10150/612064 |